Illness	Number of cases
Hyperplasia of prostate (N40)	147
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0)	118
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	59
Calculus of kidney and ureter - Calculus of kidney (N20.0)	50
Malignant neoplasm of prostate (C61)	40
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	32
Calculus of kidney and ureter - Calculus of ureter (N20.1)	24
Cystitis (N30.1)	21
Other disorders of urinary system - Stress incontinence female male (N39.3)	20
Cystitis (N30.2)	17

Top 10 treatments

Treatment	Number
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	129
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	109
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	108
Insertion, exchange or removal of a ureteral stent (8-137.00)	77
Insertion, exchange or removal of a ureteral stent (8-137.10)	63
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	60
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.8)	55
Examination of the ureter by endoscopy (1-665)	50
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4)	48
Examination of the ureter and the renal pelvis with a tube-shaped instrument with a camera mounted at the end (endoscope) (5-98b.0)	46

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
52	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
43	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
43	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at universities of applied sciences

Training

No.	Training in other healing professions	Comment
HB15	Anaesthesia technical assistant (m/f)
HB03	Physical therapist / physiotherapist (m/f)	Es werden Praktikumsplätze für Auszubildende angeboten.
HB19	Nursing professionals
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB10	Midwife (m/f)
HB07	Surgical technical assistant (m/f)